The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 30, 2019

Filed:

Jul. 23, 2015
Applicant:

Piramal Enterprises Limited, Mumbai, IN;

Inventors:

Sanjay Kumar, Mumbai, IN;

Rajiv Sharma, Fremont, CA (US);

Vijaykumar Bhagwan Deore, Mumbai, IN;

Nilambari Nilkanth Yewalkar, Pune, IN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 409/04 (2006.01); C07D 405/14 (2006.01); C07D 215/14 (2006.01); C07C 59/72 (2006.01); C07C 255/46 (2006.01); C07C 255/54 (2006.01); C07D 213/73 (2006.01); C07D 309/24 (2006.01); C07D 333/16 (2006.01); C07D 405/04 (2006.01); C07D 277/64 (2006.01); C07D 213/30 (2006.01); C07D 213/64 (2006.01); C07D 307/79 (2006.01); C07C 59/66 (2006.01);
U.S. Cl.
CPC ...
C07D 409/04 (2013.01); C07C 59/66 (2013.01); C07C 59/72 (2013.01); C07C 255/46 (2013.01); C07C 255/54 (2013.01); C07D 213/30 (2013.01); C07D 213/64 (2013.01); C07D 213/73 (2013.01); C07D 215/14 (2013.01); C07D 277/64 (2013.01); C07D 307/79 (2013.01); C07D 309/24 (2013.01); C07D 333/16 (2013.01); C07D 405/04 (2013.01); C07D 405/14 (2013.01); C07C 2601/02 (2017.05); C07C 2601/10 (2017.05); C07C 2601/14 (2017.05); C07C 2601/16 (2017.05); C07C 2601/18 (2017.05); C07C 2602/06 (2017.05); C07C 2602/08 (2017.05); C07C 2602/28 (2017.05);
Abstract

The present invention relates to substituted phenyl alkanoic acid compounds designated as the compound of Formula (I) (as described herein) or a tautomer, a stereoisomer, a geometrical isomer, a pharmaceutically acceptable salt, a pharmaceutically acceptable solvate, a prodrug, a polymorph, an N-oxide, a S-oxide or a carboxylic acid isostere thereof; which are GPR120 agonists. The present invention also relates to a pharmaceutical composition of compound of Formula (I) for the treatment of diseases or disorder mediated by GPR120.


Find Patent Forward Citations

Loading…